You are unable to access product pages.

Welcome to EKO Labs USA

Some products offered by EKO Labs USA may be FDA-approved products supplied through licensed laboratory channels, while other products are intended for laboratory research use only.

By entering this website, you confirm that you are at least 21 years old, understand that product eligibility depends on regulatory status and professional verification, and agree to follow all applicable laws and requirements.

By clicking “I Agree,” you confirm:

  • You are at least 21 years of age.
  • You understand product access may depend on product category, regulatory status, and professional verification.
  • You agree to follow all applicable laws and requirements.
  • You understand EKO Labs USA does not provide medical advice, diagnosis, treatment recommendations, dosage guidance, or patient-specific instructions through this website.

Retatrutide + Trizepatide

Retatrutide 20mg + Tirzepatide 40mg | 60 mg | Purity > 99.5%
Targets obesity and type 2 diabetes through dual and triple incretin receptor agonism (GLP-1, GIP, GCG). Retatrutide is a triple agonist in Phase 3 trials, while Tirzepatide is a dual agonist approved for type 2 diabetes. Both work by suppressing appetite, delaying gastric emptying, and improving insulin sensitivity, blood glucose, and lipid metabolism. 
not a health supplement
not intended for oral consumption.

Description

Retatrutide 20mg + Tirzepatide 40mg is a research compound combination studied for its potential role in metabolic regulation, appetite control, and blood glucose management. It is widely used in laboratory settings exploring obesity, type 2 diabetes, and energy balance through incretin pathway activity.Researchers are investigating this dual and triple receptor agonist approach for its possible effects on GLP-1, GIP, and glucagon signaling, with outcomes related to insulin sensitivity, lipid metabolism, satiety, and body weight regulation. It is often studied in advanced metabolic and endocrine research models.This product is intended strictly for laboratory and research use only. It is not approved for human consumption, medical treatment, or therapeutic application, and should only be handled by qualified professionals.

Maximum Fat Reduction

Targets visceral and overall body fat for rapid weight loss.

Enhanced Metabolic Control

Lowers HbA1c, improves insulin sensitivity, and balances lipids.

Triple-G Receptor

Targets GIP, GLP-1 and glucagon to reduce hunger and boost energy levels

Benefits

Boost your confidence and feel energized every day.

Blood Sugar Reduction

Activates GLP-1, GIP, GCG to boost insulin, reduce glucagon, slow gastric emptying, lowering fasting blood glucose, postprandial blood glucose, and glycated hemoglobin levels.

Weight Loss

Triple receptor action suppresses appetite, increases a feeling of fullness, reduces calorie intake, boosts fat loss and metabolism.

Metabolic Improvement

Reduces body fat percentage and waist size, improves insulin resistance, and helps lipid and blood pressure abnormalities.

Improved Satiety

Increases feelings of fullness after meals, helping reduce hunger and prevent frequent snacking or overeating.

Frequently Asked
Questions 

What are the mechanisms behind Retatrutide's triple agonism?
Activates GIP, GLP-1, and glucagon receptors to boost insulin, suppress appetite, and improve metabolism.
Triple and dual agonists show stronger weight loss and metabolic improvements than GLP-1 alone.
Yes, Retatrutide is in Phase 3 trials for obesity and type 2 diabetes.
Approved for type 2 diabetes; reduces blood glucose, HbA1c, and body weight.
Retatrutide may offer stronger weight loss due to triple receptor action, but it’s not FDA-approved.
High-dose use is experimental and not standard; consult a healthcare professional before use.

Frequently Asked
Questions 

Why do I need an account to purchase?

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.

EkoPeptides operates exclusively with licensed practitioners and authorized distributors. An account ensures credential verification, correct tier assignment, and compliance with our Intended Use Policy. Direct to-consumer resale without oversight is prohibited.